Hologic (HOLX) shares undervalued - Needham & Company
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Needham & Company Upgrades Hologic (HOLX) to Buy as COVID-related headwind will soon end
July 14, 2023 6:51 AM EDT(Updated - July 14, 2023 7:48 AM EDT)
Needham & Company analyst Mike Matson upgraded Hologic (NASDAQ: HOLX) from Hold to Buy with a price target of $95.00.
The analyst commented, "We are upgrading HOLX shares to Buy from Hold. We think the... More
